We are live on
!
Find out more
WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
1-Year Est. Return
17.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$310M
AUM Growth
-$281M
(-48%)
Cap. Flow
-$263M
Cap. Flow
% of AUM
-84.79%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
3
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
AUTL
Autolus Therapeutics
AUTL
|
+$126M |
| 2 |
Prothena Corp
PRTA
|
+$92.7M |
| 3 |
NCNA
NuCana
NCNA
|
+$22M |
| 4 |
Theravance Biopharma
TBPH
|
+$16.4M |
| 5 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
+$6.34M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Theravance Biopharma
TBPH
$877M
| $221M | 71.3% |
11,350,719
-809,261
| -7% | -$16.4M |
|
|
EVFM
2
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $63M | 20.31% |
833,081
-82,508
| -9% | -$6.34M |
|
|
AUTL
3
Autolus Therapeutics
AUTL
$386M
| $26M | 8.39% |
2,095,127
-9,499,107
| -82% | -$126M |
|
|
NCNA
4
NuCana
NCNA
$5.45M
| – | – |
-424
| Closed | -$22M |
|
|
5
Prothena Corp
PRTA
$452M
| – | – |
-8,773,790
| Closed | -$92.7M |
|
Similar funds
LCM
GWA
NC
IPC
AEPG
AR
KCM
ECAU